戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ivity associated with the choA orthologue in Bacteroides fragilis.
2 ivated lamina propria lymphocytes (LPLs), or Bacteroides fragilis.
3 Sp1 and our previously determined PS A2 from Bacteroides fragilis.
4 pared cell extracts of the obligate anaerobe Bacteroides fragilis.
5 semination of antibiotic resistance genes in Bacteroides fragilis.
6  alkyl hydroperoxide reductase (ahp) gene in Bacteroides fragilis.
7 ivalis but not that from Escherichia coli or Bacteroides fragilis.
8 identical residues) to the RecA protein from Bacteroides fragilis.
9 ulture of which grew E. coli, Prevotella and Bacteroides fragilis.
10 I from the anaerobic Gram-negative bacterium Bacteroides fragilis.
11 icobacter pylori, Clostridium difficile, and Bacteroides fragilis.
12 nsal bacteria including Escherichia coli and Bacteroides fragilis.
13 homologue of RprY, a response regulator from Bacteroides fragilis.
14 n of dizinc metallo-beta-lactamase CcrA from Bacteroides fragilis.
15 ts containing Escherichia coli (150 CFU) and Bacteroides fragilis (10(4) CFU) into the abdominal cavi
16 polysaccharide biosynthesis locus, PS B2, of Bacteroides fragilis 638R are described, and the sequenc
17 ysaccharide, PS A2, from the clinical strain Bacteroides fragilis 638R.
18 e (FKP), a bifunctional enzyme isolated from Bacteroides fragilis 9343, which converts l-fucose into
19 nimals with the ubiquitous gut microorganism Bacteroides fragilis, a bacterial polysaccharide (PSA) d
20 label various commensal anaerobes, including Bacteroides fragilis, a common and immunologically impor
21                                              Bacteroides fragilis, a component of the normal intestin
22 tic mechanism of metallo-beta-lactamase from Bacteroides fragilis, a dinuclear Zn(II)-containing enzy
23                                              Bacteroides fragilis, a Gram-negative colonic bacterium,
24 lates of several bacterial strains including Bacteroides fragilis, a pathogen commonly found in suppu
25                                     Although Bacteroides fragilis accounts for only 0.5% of the norma
26 demonstrate that the prominent gut commensal Bacteroides fragilis activates the TLR pathway to establ
27 hich is produced by the intestinal commensal Bacteroides fragilis, activates CD4+ T cells, resulting
28  efficient capsule biogenesis in E. coli and Bacteroides fragilis also depends on processive antiterm
29           The obligately anaerobic bacterium Bacteroides fragilis, an opportunistic pathogen and inha
30 plex between the metallo-beta-lactamase from Bacteroides fragilis and 4-morpholinoethanesulfonic acid
31   C57B/6 mice were untreated or treated with Bacteroides fragilis and antibiotic-mediated depletion o
32 : C57B/6 mice were untreated or treated with Bacteroides fragilis and antibiotic-mediated depletion o
33                           The combination of Bacteroides fragilis and Bacillus subtilis consistently
34 tative oriT region necessary for transfer in Bacteroides fragilis and Escherichia coli.
35 t dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tet
36 cificity of the metallo-beta-lactamases from Bacteroides fragilis and other similar organisms is the
37 ave protein O-glycosylation systems, that of Bacteroides fragilis and related species is unique in th
38 g LPS structures of various bacteria such as Bacteroides fragilis and Salmonella abortus are observed
39 gainst abscesses induced by bacteria such as Bacteroides fragilis and Staphylococcus aureus.
40 olysaccharide C (PS C) biosynthesis locus of Bacteroides fragilis and to determine whether distinct l
41 n new work with and vaccine development with Bacteroides fragilis and Yersinia, Shigella, and Salmone
42  pathogens, including Staphylococcus aureus, Bacteroides fragilis, and a combination of Enterococcus
43 ntibiofilm effects on Staphylococcus aureus, Bacteroides fragilis, and Candida albicans are investiga
44  mixed cultures containing Escherichia coli, Bacteroides fragilis, and Clostridium perfringens.
45 ing Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, and colibactin-producing Escherich
46 uding those found in Haemophilus influenzae, Bacteroides fragilis, and Proteus mirabilis.
47 ed to Stenotrophomonas maltophilia, to a few Bacteroides fragilis, and to rare pathogens.
48 hpCF, dps, and katB in the obligate anaerobe Bacteroides fragilis are controlled by the redox-sensiti
49                                   Strains of Bacteroides fragilis associated with diarrhea in childre
50                                   Strains of Bacteroides fragilis associated with diarrheal disease (
51  (Omp200, composed of Omp121 and Omp71) from Bacteroides fragilis ATCC 25285 was purified and tryptic
52            The proteinase was recovered from Bacteroides fragilis ATCC 25285(pFD340-prtP) cells by 3-
53 d to T-cell stimulating immunogen PS A1 from Bacteroides fragilis ATCC 25285/NCTC 9343 via a physiolo
54 etobacter baumannii, Neisseria meningitidis, Bacteroides fragilis, Bacillus anthracis, Yersinia pesti
55 g glycoantigen (GlyAg) polysaccharide A from Bacteroides fragilis but not conventional peptides.
56 el is inconsistent with the observation that Bacteroides fragilis can colonize the colon in the absen
57                                              Bacteroides fragilis can replicate in atmospheres contai
58 rom the Gram-negative opportunistic pathogen Bacteroides fragilis, can rescue the ultraviolet sensiti
59                                          The Bacteroides fragilis capsular polysaccharide complex is
60 gulatory mechanism is similar to that of the Bacteroides fragilis capsular polysaccharides and establ
61 s directed to a preferred target site in the Bacteroides fragilis chromosome by a transposon-encoded
62 7, a new 52-kb transfer factor isolated from Bacteroides fragilis clinical isolate LV23.
63 nd was isolated from an antibiotic resistant Bacteroides fragilis clinical isolate.
64 developed to detect the bft gene subtypes in Bacteroides fragilis clinical isolates.
65 lent bacterial gastrointestinal inhabitants: Bacteroides fragilis, Clostridium perfringens, Escherich
66                                          The Bacteroides fragilis conjugal plasmid pBFTM10 contains t
67                                 The symbiont Bacteroides fragilis constitutes a relatively small prop
68                                              Bacteroides fragilis constitutes about 1% of the bacteri
69 nt of MIA offspring with the human commensal Bacteroides fragilis corrects gut permeability, alters m
70                          The human commensal Bacteroides fragilis delivers immunomodulatory molecules
71                                              Bacteroides fragilis-derived LPS, however, can effective
72 s of two Uxs-type UDP-GlcA decarboxylases of Bacteroides fragilis, designated BfUxs1 and BfUxs2.
73 de, PSA, produced by the commensal bacterium Bacteroides fragilis directs development of the immune s
74 ort herein that a prominent human commensal, Bacteroides fragilis, directs the development of Foxp3(+
75 enzyme from Bacillus cereus differs from the Bacteroides fragilis enzyme in sequence, zinc stoichiome
76 inally in two Bacteroides clinical isolates, Bacteroides fragilis ERL and B. thetaiotaomicron DOT.
77 taphylococci (CNS), Peptostreptococcus spp., Bacteroides fragilis, Escherichia coli, Enterococcus spp
78                              Enterotoxigenic Bacteroides fragilis (ETBF) causes diarrhea and is impli
79                              Enterotoxigenic Bacteroides fragilis (ETBF) cells produce a 20-kDa heat-
80                              Enterotoxigenic Bacteroides fragilis (ETBF) has been implicated in infla
81 tinal disease, the bacterium enterotoxigenic Bacteroides fragilis (ETBF) is a significant source of c
82          The human commensal enterotoxigenic Bacteroides fragilis (ETBF) is linked to both inflammato
83                              Enterotoxigenic Bacteroides fragilis (ETBF) produces the Bacteroides fra
84                              Enterotoxigenic Bacteroides fragilis (ETBF) secretes a 20-kDa metallopro
85                              Enterotoxigenic Bacteroides fragilis (ETBF) strains produce a 20-kDa zin
86                              Enterotoxigenic Bacteroides fragilis (ETBF) strains, which produce a 20-
87 gens, Arcobacter species and enterotoxigenic Bacteroides fragilis (ETBF), in 201 U.S. and European tr
88 ith the human gut bacterium, enterotoxigenic Bacteroides fragilis (ETBF), to investigate the link bet
89                The burden of enterotoxigenic Bacteroides fragilis (ETBF)-related diarrhea was determi
90 y a human colonic bacterium, enterotoxigenic Bacteroides fragilis (ETBF).
91 at may promote such competition, we screened Bacteroides fragilis for the production of antimicrobial
92                                              Bacteroides fragilis, for example, synthesizes eight cap
93                                              Bacteroides fragilis GA3 is known to mediate potent inte
94                                            A Bacteroides fragilis gene (argF'(bf)), the disruption of
95 .6%), Porphyromonas species (11.3%), and the Bacteroides fragilis group (10.2%).
96   The predominant anaerobes were as follows: Bacteroides fragilis group (85 isolates), Peptostreptoco
97 (n = 43), Sphingobacterium spp. (n = 3), and Bacteroides fragilis group (n = 15).
98               The predominant anaerobes were Bacteroides fragilis group (n = 9) and Peptostreptococcu
99                               Members of the Bacteroides fragilis group are among the most common ana
100                                         More Bacteroides fragilis group bacteremias were detected onl
101 which phenotypically resemble members of the Bacteroides fragilis group but phylogenetically display
102 robial susceptibility data of species of the Bacteroides fragilis group for 1989-1990 and 1998-1999 s
103 s bile sensitive and quite distinct from the Bacteroides fragilis group of anaerobes.
104 ntly better for several genera including the Bacteroides fragilis group, Fusobacterium, Clostridium,
105               One member of this family from Bacteroides fragilis had exquisite substrate specificity
106                    Here, we demonstrate that Bacteroides fragilis has a general O-glycosylation syste
107                       The human gut symbiont Bacteroides fragilis has a general protein O-glycosylati
108                              Enterotoxigenic Bacteroides fragilis has been associated with diarrheal
109 nine biosynthesis in the anaerobic bacterium Bacteroides fragilis has been purified and crystallized
110                            The chromosome of Bacteroides fragilis has been shown to undergo 13 distin
111 olymerization of polysaccharide A (PSA) from Bacteroides fragilis in the endosome depends on the APC'
112 specificity metallo-beta-lactamase CcrA from Bacteroides fragilis in the presence and absence of a ti
113                                  Survival of Bacteroides fragilis in the presence of oxygen was depen
114  We report a case of metronidazole-resistant Bacteroides fragilis in the United States and demonstrat
115 ssion of CcrA, a metallo-beta-lactamase from Bacteroides fragilis, in Escherichia coli requires a mut
116 munomodulatory molecule of the gut commensal Bacteroides fragilis, induces regulatory T cells to secr
117 ate early-phase immunologic events following Bacteroides fragilis infection in the peritoneal cavity,
118 g bacteria such as Staphylococcus aureus and Bacteroides fragilis initiate this host response when tr
119 tin capsules containing Escherichia coli and Bacteroides fragilis into the abdomens of rats (n = 9).
120                   The opportunistic pathogen Bacteroides fragilis is a commensal organism in the larg
121                                              Bacteroides fragilis is a constituent of the normal resi
122                                 The anaerobe Bacteroides fragilis is a gram-negative, opportunistic p
123                                 The anaerobe Bacteroides fragilis is a highly aerotolerant, opportuni
124                                              Bacteroides fragilis is a member of the normal colonic m
125 t polysaccharide A (PSA) from the capsule of Bacteroides fragilis is a potent activator of CD4(+) T c
126                    Enterotoxigenic anaerobic Bacteroides fragilis is a significant source of inflamma
127 jor clinical manifestation of infection with Bacteroides fragilis is the formation of intra-abdominal
128                                              Bacteroides fragilis is the leading cause of anaerobic b
129                                              Bacteroides fragilis is the most common anaerobe isolate
130                       The obligate anaerobe, Bacteroides fragilis, is a highly aerotolerant intestina
131          The human intestinal microorganism, Bacteroides fragilis, is able to extensively modulate it
132 strate that the human colonic microorganism, Bacteroides fragilis, is able to modulate its surface an
133           The intestinal anaerobic symbiont, Bacteroides fragilis, is highly aerotolerant and resista
134 d that the anaerobic, opportunistic pathogen Bacteroides fragilis lacks the glutathione/glutaredoxin
135 of Tn5520, a new mobilizable transposon from Bacteroides fragilis LV23.
136  coli R1, Pseudomonas aeruginosa PAC608, and Bacteroides fragilis), mixed together to form a cocktail
137  Here, we report that the intestinal microbe Bacteroides fragilis modifies the homeostasis of host in
138                                            A Bacteroides fragilis mutant resistant to hydrogen peroxi
139                  We previously showed that a Bacteroides fragilis mutant unable to synthesize 4 of th
140 onic capsular polysaccharide of the anaerobe Bacteroides fragilis NCTC 9343, designated polysaccharid
141 ry to identify the sphingolipids produced by Bacteroides fragilis NCTC 9343.
142 ements were found in the genome sequences of Bacteroides fragilis NCTC9343 and Bacteroides thetaiotao
143             The genetic element flanking the Bacteroides fragilis pathogenicity island (BfPAI) in ent
144 yl-(1-3)-beta-glucopyranose (PGG)-glucan and Bacteroides fragilis polysaccharide A (PS A), were evalu
145 icha coli, beta-hemolytic streptococcus, and Bacteroides fragilis predominating.
146  metabolites, but symptoms are relieved by a Bacteroides fragilis probiotic.
147                   Enterotoxigenic strains of Bacteroides fragilis produce an extracellular metallopro
148                                              Bacteroides fragilis produces a capsular polysaccharide
149                                              Bacteroides fragilis produces a capsular polysaccharide
150 n CNS demyelination, and we demonstrate that Bacteroides fragilis producing a bacterial capsular poly
151 investigated the cellular mechanism by which Bacteroides fragilis promotes the development of intraab
152                                  In the gut, Bacteroides fragilis protects against colitis through in
153 eport here that the prominent human symbiont Bacteroides fragilis protects animals from experimental
154 is factor for the human intestinal commensal Bacteroides fragilis, protects against central nervous s
155                                           In Bacteroides fragilis, PS synthesis is regulated so that
156 unomodulatory effects of the archetypal ZPS, Bacteroides fragilis PSA.
157 ysaccharides in the important human symbiont Bacteroides fragilis raised the critical question of how
158                               We reveal that Bacteroides fragilis releases PSA in outer membrane vesi
159 ebsiella oxytoca, Staphylococcus aureus, and Bacteroides fragilis remains largely undefined and test
160 mmensal bacteria, Bifidobacterium longum and Bacteroides fragilis, representative members of the gut
161 F1687 proteins from Bacteroides vulgatus and Bacteroides fragilis respectively are members of the Pfa
162 tion of the ccf genes in the model symbiont, Bacteroides fragilis, results in colonization defects in
163 -terminal sequence of sialidases produced by Bacteroides fragilis SBT3182, another commensal enteric
164 pellets inoculated with Escherichia coli and Bacteroides fragilis (sepsis).
165 ng animals with polysaccharide A (PS A) from Bacteroides fragilis shortly before or after challenge p
166 /-7 motifs (TTTG/TANNTTTG) were identical to Bacteroides fragilis sigma(ABfr) consensus -33/-7 promot
167 atalysis of metallo-beta-lactamase CcrA from Bacteroides fragilis, site-directed mutants of CcrA were
168  function of the metallo-beta-lactamase from Bacteroides fragilis, spectroscopic and metal-binding st
169  capsular polysaccharides of many strains of Bacteroides fragilis, Staphylococcus aureus, and Strepto
170     YT135.2.8, a Tn4400' insertion mutant of Bacteroides fragilis strain TM4000, grows poorly when us
171                              Enterotoxigenic Bacteroides fragilis strains associated with childhood d
172                                              Bacteroides fragilis, Streptococcus pneumoniae, Prevotel
173 cillospira, Rickenellaceae, Parabacteroides, Bacteroides fragilis, Sutterella, Lachnospiraceae, 4-met
174  switching roles between the two species (as Bacteroides fragilis switches roles between humans and m
175                           A single strain of Bacteroides fragilis synthesizes eight distinct capsular
176                                              Bacteroides fragilis synthesizes eight distinct capsular
177 tly nonmotile (Bacteroides thetaiotaomicron, Bacteroides fragilis, Tannerella forsythensis, Porphyrom
178                                   Strains of Bacteroides fragilis that produce a ca. 20-kDa heat-labi
179                              Enterotoxigenic Bacteroides fragilis that secrete a zinc-dependent metal
180  factor contributing to the pathogenicity of Bacteroides fragilis, the most common anaerobic species
181                                              Bacteroides fragilis, though only a minor component of t
182 valuate the role of the C-terminal region in Bacteroides fragilis toxin (BFT) activity, processing, a
183                                          The Bacteroides fragilis toxin (BFT) is the only known virul
184  role of the zinc-binding metalloprotease in Bacteroides fragilis toxin (BFT) processing and activity
185 high-level expression of biologically active Bacteroides fragilis toxin (BFT), we studied the express
186  The only known ETBF virulence factor is the Bacteroides fragilis toxin (BFT), which induces E-cadher
187 nic Bacteroides fragilis (ETBF) produces the Bacteroides fragilis toxin, which has been associated wi
188                    A modified version of the Bacteroides fragilis transposon Tn4400, designated Tn440
189 P. gingivalis with a modified version of the Bacteroides fragilis transposon Tn4400.
190 ntained on conserved ICE and are confined to Bacteroides fragilis Unlike GA1 and GA2 T6SS loci, most
191 the reaction pathway for binuclear CcrA from Bacteroides fragilis using density functional theory bas
192  tyrosine site-specific recombinase (Tsr) of Bacteroides fragilis was characterized.
193 atB catalase gene in the anaerobic bacterium Bacteroides fragilis was studied.
194 a sixth target, the zinc beta-lactamase from Bacteroides fragilis, was screened against the fragment-
195 lysaccharide biosynthesis locus promoters of Bacteroides fragilis were determined from bacteria grown
196 f the opportunistic human anaerobic pathogen Bacteroides fragilis, which is currently classified as a
197        We characterized the nanLET operon in Bacteroides fragilis, whose products are required for th
198 of Escherichia coli, Neisseria meningitidis, Bacteroides fragilis, Yersinia pestis, Chlamydia trachom
199 MD) simulations of the dinuclear form of the Bacteroides fragilis zinc beta-lactamase.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top